Biokapital- R&D
     
09.06.10

Investor Relations

BioKapital AS with portfolio companies will actively use investor relations to build value.  

 

Potential new investors will be evaluated based on :

  • Interest in the economic potential of reproduction and genetics
  • Know-how in biotech and strategy work
  • Access to wider networks and value chains
  • Access to capital

BioKapital has implemented guidelines for Best Ownership Practice, which are enforced in BioKapital AS and portfolio companies. This to ensure that BioKapital and investors are working to optimize shareholders' values. 

 

We welcome interested investors to contact us.

 

Print RSS
      | More
BioKapital AS, Holsetgata 22, N-2317 Hamar, Norway Phone: +47 950 20 600 Fax: +47 62 52 06 01
E-mail: post@biokapital.no
VAT Reg. 993130532
 
Infoboks